8-K: AMN Healthcare Announces First Quarter 2025 Results: Revenue Above Guidance, But Profitability Declines

AMN Healthcare reported Q1 2025 revenue of $690 million, exceeding guidance, but experienced a net loss of ($0.03) per share and a decrease in adjusted EPS to $0.45.

Summary

• AMN Healthcare Services, Inc. announced its first quarter 2025 financial results, with revenue reaching $690 million.
• This represents a 16% decrease compared to the prior year and a 6% decrease from the previous quarter.
• The company reported a net loss of $1 million, or ($0.03) per diluted share, a significant drop from the $17 million net income, or $0.45 per diluted share, in Q1 2024.
• Adjusted diluted EPS was $0.45, down from $0.97 in the same quarter last year.
• Revenue for Nurse and Allied Solutions was $413 million, a 20% year-over-year decrease and a 9% sequential decrease.
• Physician and Leadership Solutions generated $174 million in revenue, down 8% year over year but up 1% sequentially.
• Technology and Workforce Solutions revenue was $102 million, a 9% decrease year over year and a 4% sequential decrease.
• The company's gross margin was 28.7%, a decrease of 270 basis points year over year.
• SG&A expenses were $148 million, or 21.4% of revenue, compared to $175 million, or 21.3% of revenue, in the same quarter last year.
• Adjusted EBITDA was $64 million, a 34% year-over-year decrease, with an adjusted EBITDA margin of 9.3%.
• Cash flow from operations was strong at $93 million, enabling a $60 million debt reduction.
• The net leverage ratio at the end of the quarter was 3.1:1.
• For the second quarter of 2025, AMN Healthcare projects consolidated revenue between $645 and $660 million.
• The company expects a gross margin between 28.5% and 29.0% and an adjusted EBITDA margin between 7.8% and 8.3%.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While revenue exceeded guidance, profitability declined significantly. The company is taking steps to reduce debt and manage costs, but the overall financial performance is mixed.

Positives

• First quarter revenue and earnings were above the high end of guidance.
• Consolidated gross margin was better than guidance.
• Effective SG&A management delivered operating leverage.
• Improved bookings driven by technology and process improvements grew locum tenens revenue sequentially.
• Cash flow from operations was strong at $93 million, which allowed the company to reduce debt by $60 million.

Negatives

• Consolidated revenue for the quarter was $690 million, a 16% decrease from prior year and a 6% decrease from the prior quarter.
• Net loss was $1 million (0.2% of revenue), or ($0.03) per diluted share, compared with net income of $17 million (2.1% of revenue), or $0.45 per diluted share, in the first quarter of 2024.
• Adjusted diluted EPS in the first quarter was $0.45 compared with $0.97 in the same quarter a year ago.
• Consolidated gross margin was 28.7%, 270 basis points lower year over year and down 110 basis points sequentially.
• Income from operations was $13 million with an operating margin of 1.8%, compared with $40 million and 4.9%, respectively, in the same quarter last year.
• Adjusted EBITDA was $64 million, a year-over-year decrease of 34%.
• Adjusted EBITDA margin was 9.3%, 260 basis points lower than the year-ago period.

Risks

• Clients remain cost-conscious and are monitoring possible impacts from tariffs and healthcare regulatory and legislative proposals.
• The company's future performance depends on its ability to address client demand by attracting and placing nurses and other clinicians.
• The company's future performance depends on its ability to recruit and retain sufficient quality healthcare professionals at reasonable costs.
• The company's future performance depends on its ability to anticipate and quickly respond to changing marketplace conditions.
• Economic downturns, inflation or slow recoveries could result in less demand for the company's services.
• Security breaches and cybersecurity incidents could compromise the company's information and systems.

Future Outlook

AMN Healthcare expects second quarter 2025 consolidated revenue to be between $645 and $660 million, with a gross margin between 28.5% and 29.0% and an adjusted EBITDA margin between 7.8% and 8.3%.

Management Comments

• Our financial results for the first three months of 2025 yielded positive upside in revenue and operating leverage, said Cary Grace, President and Chief Executive Officer of AMN Healthcare.
• We are benefiting from growth in our clients' patient volumes, continued normalization in our industry, and market adoption of our tech-enabled talent solutions.
• We continue to be confident in our opportunity to gain market share and increase revenue over time through our diversified suite of healthcare workforce solutions.

Industry Context

The announcement reflects the ongoing normalization in the healthcare staffing industry post-COVID-19, with a focus on technology-enabled solutions and cost management. AMN Healthcare is positioning itself to gain market share through its diversified service offerings.

Comparison to Industry Standards

• Comparing AMN Healthcare's performance to competitors like Cross Country Healthcare and Team Health, the revenue decline is within the expected range given the industry's normalization.
• However, the decrease in profitability, as reflected in the net loss and lower adjusted EBITDA margin, raises concerns about cost management and pricing strategies compared to industry benchmarks.
• The company's focus on technology and workforce solutions aligns with industry trends, but its ability to effectively implement these solutions and achieve higher margins will be crucial for future success.

Stakeholder Impact

• Shareholders will be concerned about the net loss and decrease in adjusted EPS.
• Employees may be affected by cost management initiatives.
• Customers will benefit from the company's focus on technology-enabled solutions and workforce optimization.
• Creditors will be reassured by the company's debt reduction efforts.

Next Steps

• AMN Healthcare will host a conference call on May 8, 2025, to discuss its first quarter 2025 financial results and second quarter 2025 outlook.
• The company will continue to focus on technology and process improvements to drive revenue growth and improve profitability.

Key Dates

Keywords

AMN Healthcare, Financial Results, Healthcare Staffing, Revenue, EBITDA, EPS, Guidance